Maryland Oncology Hematology — Annapolis, Maryland

Maryland Oncology Hematology is a clinical research site located in Annapolis, Maryland, United States 21401.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Maryland Oncology Hematology has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Early Detection of Cancer, Cancer.

Sponsors: Hoffmann-La Roche, GRAIL, Inc., K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Annapolis

Browse all research sites in Maryland · View every site in Annapolis

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Maryland Oncology Hematology?

Maryland Oncology Hematology has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Maryland Oncology Hematology conducted?

Maryland Oncology Hematology has 5 clinical trials on record, with 3 currently active. Their work covers Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Early Detection of Cancer, Cancer.

Is Maryland Oncology Hematology accredited by Crixeo Clinical Trials?

Maryland Oncology Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Maryland Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.